Your browser is no longer supported. Please, upgrade your browser.
Settings
TTNP Titan Pharmaceuticals, Inc. daily Stock Chart
TTNP [NASD]
Titan Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.71 Insider Own0.30% Shs Outstand95.66M Perf Week1.21%
Market Cap29.34M Forward P/E- EPS next Y-0.15 Insider Trans0.00% Shs Float95.38M Perf Month-0.40%
Income-17.50M PEG- EPS next Q-0.04 Inst Own7.00% Short Float7.77% Perf Quarter-5.71%
Sales4.00M P/S7.33 EPS this Y7.90% Inst Trans-0.51% Short Ratio0.58 Perf Half Y19.71%
Book/sh0.06 P/B5.01 EPS next Y-15.40% ROA-201.20% Target Price- Perf Year-61.31%
Cash/sh0.08 P/C3.67 EPS next 5Y- ROE- 52W Range0.14 - 1.09 Perf YTD54.87%
Dividend- P/FCF- EPS past 5Y3.20% ROI-307.70% 52W High-72.42% Beta0.91
Dividend %- Quick Ratio2.50 Sales past 5Y-0.20% Gross Margin71.10% 52W Low111.69% ATR0.02
Employees21 Current Ratio2.80 Sales Q/Q44.40% Oper. Margin- RSI (14)43.66 Volatility4.86% 6.41%
OptionableYes Debt/Eq0.79 EPS Q/Q80.20% Profit Margin- Rel Volume0.24 Prev Close0.30
ShortableYes LT Debt/Eq0.66 EarningsMay 15 BMO Payout- Avg Volume12.77M Price0.30
Recom2.00 SMA20-1.55% SMA50-5.05% SMA20019.32% Volume3,205,802 Change0.27%
Jun-26-19Initiated Maxim Group Buy $4
Nov-10-17Downgrade ROTH Capital Buy → Neutral
Jul-08-20 08:00AM  
Jun-24-20 08:00AM  
Jun-16-20 08:00AM  
Jun-01-20 05:20AM  
May-15-20 08:45AM  
May-11-20 04:03PM  
Apr-09-20 06:15AM  
Apr-02-20 09:47PM  
Mar-31-20 12:43PM  
Mar-30-20 04:03PM  
02:30PM  
Mar-26-20 08:00AM  
Mar-05-20 09:00AM  
Feb-18-20 08:55AM  
Jan-13-20 08:00AM  
Jan-07-20 09:15AM  
Dec-30-19 08:00AM  
Dec-17-19 10:30AM  
Dec-04-19 01:22PM  
Dec-03-19 09:00AM  
Nov-25-19 05:15AM  
Nov-14-19 04:03PM  
Nov-07-19 04:30PM  
Oct-22-19 08:00AM  
Oct-18-19 10:23AM  
Oct-16-19 09:20AM  
Oct-01-19 08:00AM  
Sep-18-19 08:00AM  
Aug-30-19 08:01PM  
Aug-23-19 11:30AM  
Aug-17-19 09:59AM  
Aug-16-19 07:33AM  
Aug-14-19 04:03PM  
07:32AM  
Aug-09-19 05:00PM  
Aug-07-19 09:15AM  
Jul-09-19 09:00AM  
Jul-03-19 10:54AM  
Jun-26-19 09:10AM  
Jun-04-19 07:00AM  
May-29-19 02:15PM  
May-23-19 08:10AM  
May-15-19 04:08PM  
04:03PM  
May-13-19 07:00AM  
May-08-19 08:00PM  
May-06-19 03:12PM  
Apr-29-19 07:00AM  
Apr-12-19 05:00PM  
Apr-11-19 09:45AM  
Apr-02-19 01:06AM  
Apr-01-19 05:07PM  
04:30PM  
Mar-28-19 07:00AM  
Mar-26-19 07:00AM  
Feb-25-19 02:20PM  
07:00AM  
Feb-08-19 09:30AM  
Feb-01-19 02:31PM  
12:01PM  
11:46AM  
11:10AM  
Jan-31-19 06:36PM  
Jan-24-19 07:00AM  
Dec-21-18 12:54PM  
Dec-10-18 10:35AM  
Nov-21-18 07:25AM  
Nov-20-18 11:15AM  
Nov-14-18 04:38PM  
04:01PM  
Nov-08-18 07:00AM  
Nov-07-18 09:30AM  
Nov-05-18 08:55AM  
07:00AM  
Nov-02-18 10:30AM  
Oct-30-18 09:45AM  
Oct-29-18 08:00AM  
Oct-23-18 02:40PM  
Oct-22-18 08:00AM  
Oct-15-18 08:15AM  
Oct-02-18 07:00AM  
Sep-20-18 08:30PM  
09:32AM  
Sep-10-18 07:00AM  
Aug-20-18 05:55PM  
Aug-14-18 04:55PM  
04:35PM  
Aug-03-18 07:00AM  
Jul-02-18 04:30PM  
May-30-18 07:00AM  
May-24-18 02:03PM  
May-16-18 08:10AM  
May-15-18 04:40PM  
04:15PM  
May-14-18 07:00AM  
May-08-18 05:05PM  
Apr-12-18 09:30AM  
Apr-11-18 07:00AM  
Apr-03-18 07:16AM  
Apr-02-18 12:00PM  
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company offers Probuphine, a six-month buprenorphine implant for the maintenance treatment of opioid addiction in patients. It also develops ProNeura-Ropinirole, an implant to provide delivery of ropinirole, a dopamine agonist for the treatment of Parkinson's disease; and triiodothyronine, an implant for the treatment of hypothyroidism. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.